Phastar’s Post

Our latest blog ‘Technology led Data Driven CRO: Real World Evidence and Real World Data Services’ explores our RWD/RWE services and capabilities and gives you expert insights on how foundations can leverage clinical registry ecosystems. Access our article on RWE published in Applied Clinical Trials Magazine co-authored by our experts Sowmya Kaur, Dr Yun Lu, Susan Li and Sarah Woody Lawrence too. Read now: https://lnkd.in/gza-bGCS #RWE #Clinicalregistries #RWD #Clinicaltrials

Our latest blog ‘Technology led Data Driven CRO: Real World Evidence and Real World Data Services’ explores our RWD/RWE services and capabilities and gives you expert insights on how foundations can leverage clinical registry ecosystems. Access our article on RWE published in Applied Clinical Trials Magazine co-authored by our experts Sowmya Kaur, Dr Yun Lu, Susan Li and Sarah Woody Lawrence too. Read now: https://lnkd.in/gza-bGCS #RWE #Clinicalregistries #RWD #Clinicaltrials

Looking at historical clinical trial data allows us to better predict study outcomes. By leveraging Clinical Trials Transformation Initiative (CTTI)'s extensive repository of trial data, we’re able to use #machinelearning to make data-driven decisions and accelerate protocol development based on these predictions. Read the full case study: https://lnkd.in/e4qEkzxT #artificialintelligence #protocolwriting #clinicaltrials

It's all about Data Quality......

🌟 Real-World Evidence: Turning Data into Decisions 🌟 Today, Riikka Mattila and Johanna Vikkula from Medaffcon are attending the ISPOR Real-World Evidence Summit, where the potential of real-world data to shape impactful decisions is in the spotlight. Real-world evidence (RWE) offers incredible value throughout the healthcare landscape. It’s not just about data—it’s about insight. By leveraging RWE, we can: ✅ Build stronger foundations for economic models, ensuring they reflect realities and guide smarter resource allocation. ✅ Understand how interventions truly perform in everyday clinical settings, offering a clearer view of their impact after launch. ✅ Assess the transportability of clinical trials to local Nordic patient populations At Medaffcon, we’re committed to turning data into actionable insights that make a real world difference. Let’s connect to explore how RWE can transform decision-making in healthcare together! #ISPORSummit #ISPOREurope #RWE #Medaffcon

Making the Most of Real-World Data in Clinical Trials https://buff.ly/4aPymgY #clinicaltrials #realworlddata #RWD #clinicalresearch

Pattern Health is the new gold standard for real-world research. Here's why customers love us: Pattern's platform and supporting services directly support and solve the pain points associated with RWE studies. We empower sponsors and CROs with intuitive tools to ✅ Efficiently compile meaningful data to establish evidence of clinical, economic, and humanistic (patient-centric) value in actual practice settings. ✅ Support safety event tracking and adjudication under actual practice conditions. ✅ Minimize participant data collection burden while maximizing participant engagement (at all study stages). ✅ Appropriately access and utilize available RWD to augment prospective data collection. ✅ Support the needs of Medical Affairs / RWE / HEOR teams in conducting relevant and informative real-world research and in communicating findings. Schedule a demo to learn more about how Pattern could support your RWE studies: https://loom.ly/CRfoFvg

➡️Using real-world data (RWD) in clinical research offers crucial advantages: ➕Increased representativeness: RWD includes a wide variety of real-world patients and conditions, improving generalizability of findings. ✔️Efficiency: Rapid access to large volumes of data through advanced tools, reducing time and administrative burdens. ➖Cost reduction: Minimizes collection costs and optimizes resource allocation, driving more cost-effective studies. 🔷The integration of real-world data into clinical research, facilitated by IOMED technology, represents a significant evolution towards research that is faster, more efficient, cost-effective and representative of everyday clinical practice. #RWD #RealWorldData #HealthData #HospitalData #ClinicalResearch #IOMED

Collecting Real-World Data (RWD) during an Expanded Access Program provides a unique opportunity for Biotechs. With an EAP, you can: 👉 have access to a broader and diverse population 👉 gather data outside the controlled clinical trial environment 👉 collect long-term data on drug performance and patient outcomes To learn more, visit: https://lnkd.in/gBzNmGyv #ExpandedAccessPrograms #RareDiseases #OrphanDrugs #RealWorldEvidence

A more clinical approach for clinical studies! We've recently provided a new tailored digital analytics solution for Sosei Heptares, giving them full control over all the processes and data from their clinical studies. Full story here: https://lnkd.in/gnNuYf3Z